Michele B. Kaufman, PharmD, CGP, RPh, is a freelance medical writer based in New York City and a pharmacist at New York Presbyterian Lower Manhattan Hospital.
- MorphoSys AG. News release: MorphoSys licensing partner GSK starts phase 2 study with GSK3196165 (MOR103) in hand osteoarthritis. 2016 Apr 18.
- U.S. National Institutes of Health. A study to investigate the efficacy and safety of GSK3196165 in inflammatory hand osteoarthritis. NCT02683785. ClinicalTrials.gov. 2016 Apr 28.
- U.S. National Institutes of Health. Study to evaluate the efficacy and safety of GSK3196165 plus methotrexate in subjects with active moderate-severe rheumatoid arthritis. NCT02504671. ClinicalTrials.gov. 2016 Jan 14.
- Regeneron Pharmaceuticals Inc. News release: Regeneron announces positive topline results from phase 2/3 fasinumab study in patients with osteoarthritis pain. 2016 May 2.